Chubb Valuation

Is CB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CB ($285.21) is trading below our estimate of fair value ($563.29)

Significantly Below Fair Value: CB is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CB?

Key metric: As CB is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CB. This is calculated by dividing CB's market cap by their current earnings.
What is CB's PE Ratio?
PE Ratio11.5x
EarningsUS$10.00b
Market CapUS$114.97b

Price to Earnings Ratio vs Peers

How does CB's PE Ratio compare to its peers?

The above table shows the PE ratio for CB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average14.3x
PGR Progressive
19.3x-0.1%US$155.9b
TRV Travelers Companies
13.2x2.8%US$59.6b
ALL Allstate
13.1x4.8%US$54.0b
HIG Hartford Financial Services Group
11.6x7.7%US$35.0b
CB Chubb
11.5x1.0%US$115.0b

Price-To-Earnings vs Peers: CB is good value based on its Price-To-Earnings Ratio (11.5x) compared to the peer average (14.3x).


Price to Earnings Ratio vs Industry

How does CB's PE Ratio compare vs other companies in the US Insurance Industry?

3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
2xn/aUS$89.08m
AORE.F American Overseas Group
2.1xn/aUS$16.68m
CUII China United Insurance Service
0.0003xn/aUS$3.13k
No more companies available in this PE range
CB 11.5xIndustry Avg. 13.7xNo. of Companies15PE01020304050+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CB is good value based on its Price-To-Earnings Ratio (11.5x) compared to the US Insurance industry average (13.7x).


Price to Earnings Ratio vs Fair Ratio

What is CB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CB PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.5x
Fair PE Ratio14.5x

Price-To-Earnings vs Fair Ratio: CB is good value based on its Price-To-Earnings Ratio (11.5x) compared to the estimated Fair Price-To-Earnings Ratio (14.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$285.21
US$298.91
+4.8%
8.2%US$349.00US$245.00n/a21
Nov ’25US$277.41
US$297.71
+7.3%
8.3%US$349.00US$245.00n/a21
Oct ’25US$292.12
US$282.96
-3.1%
8.5%US$349.00US$236.00n/a22
Sep ’25US$284.18
US$277.86
-2.2%
6.4%US$305.00US$236.00n/a21
Aug ’25US$271.95
US$276.43
+1.6%
6.7%US$305.00US$236.00n/a21
Jul ’25US$254.82
US$270.73
+6.2%
5.5%US$305.00US$236.00n/a22
Jun ’25US$270.82
US$269.50
-0.5%
5.0%US$294.00US$236.00n/a22
May ’25US$249.93
US$266.65
+6.7%
6.3%US$297.00US$226.00n/a23
Apr ’25US$257.40
US$261.17
+1.5%
7.2%US$285.00US$226.00n/a23
Mar ’25US$250.62
US$259.13
+3.4%
7.3%US$285.00US$226.00n/a23
Feb ’25US$244.95
US$253.74
+3.6%
7.6%US$285.00US$220.00n/a23
Jan ’25US$226.00
US$243.68
+7.8%
7.4%US$275.00US$203.00n/a22
Dec ’24US$228.66
US$244.68
+7.0%
7.7%US$277.00US$203.00n/a22
Nov ’24US$220.31
US$244.19
+10.8%
7.6%US$277.00US$203.00US$277.4121
Oct ’24US$208.18
US$238.55
+14.6%
8.6%US$270.00US$192.00US$292.1220
Sep ’24US$203.29
US$238.55
+17.3%
8.6%US$270.00US$192.00US$284.1820
Aug ’24US$203.22
US$238.30
+17.3%
8.5%US$270.00US$192.00US$271.9520
Jul ’24US$192.56
US$237.13
+23.1%
8.9%US$270.00US$192.00US$254.8220
Jun ’24US$187.70
US$239.50
+27.6%
7.9%US$270.00US$193.00US$270.8219
May ’24US$202.14
US$241.40
+19.4%
7.7%US$270.00US$193.00US$249.9320
Apr ’24US$194.18
US$242.80
+25.0%
8.4%US$270.00US$185.00US$257.4020
Mar ’24US$209.50
US$243.70
+16.3%
7.3%US$270.00US$205.00US$250.6220
Feb ’24US$213.44
US$245.05
+14.8%
7.2%US$270.00US$205.00US$244.9520
Jan ’24US$220.60
US$235.89
+6.9%
9.4%US$270.00US$175.00US$226.0018
Dec ’23US$218.32
US$232.68
+6.6%
8.9%US$270.00US$175.00US$228.6619
Nov ’23US$213.48
US$231.30
+8.3%
9.2%US$270.00US$175.00US$220.3120

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies